BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21447639)

  • 1. Minireview: the busy road to pheochromocytomas and paragangliomas has a new member, TMEM127.
    Jiang S; Dahia PL
    Endocrinology; 2011 Jun; 152(6):2133-40. PubMed ID: 21447639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas.
    Yao L; Schiavi F; Cascon A; Qin Y; Inglada-Pérez L; King EE; Toledo RA; Ercolino T; Rapizzi E; Ricketts CJ; Mori L; Giacchè M; Mendola A; Taschin E; Boaretto F; Loli P; Iacobone M; Rossi GP; Biondi B; Lima-Junior JV; Kater CE; Bex M; Vikkula M; Grossman AB; Gruber SB; Barontini M; Persu A; Castellano M; Toledo SP; Maher ER; Mannelli M; Opocher G; Robledo M; Dahia PL
    JAMA; 2010 Dec; 304(23):2611-9. PubMed ID: 21156949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel hereditary forms of pheochromocytomas and paragangliomas.
    Dahia PL
    Front Horm Res; 2013; 41():79-91. PubMed ID: 23652672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes.
    Gimenez-Roqueplo AP; Dahia PL; Robledo M
    Horm Metab Res; 2012 May; 44(5):328-33. PubMed ID: 22328163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas.
    Bertherat J; Gimenez-Roqueplo AP
    Horm Metab Res; 2005 Jun; 37(6):384-90. PubMed ID: 16001332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of mutations in genes that predispose to hereditary paragangliomas and pheochromocytomas.
    Lefebvre S; Borson-Chazot F; Boutry-Kryza N; Wion N; Schillo F; Peix JL; Brunaud L; Finat A; Calender A; Giraud S
    Horm Metab Res; 2012 May; 44(5):334-8. PubMed ID: 22517554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Characterization of TMEM127 Variants Reveals Novel Insights into Its Membrane Topology and Trafficking.
    Flores SK; Deng Y; Cheng Z; Zhang X; Tao S; Saliba A; Chu I; Burnichon N; Gimenez-Roqueplo AP; Wang E; Aguiar RCT; Dahia PLM
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3142-56. PubMed ID: 32575117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites.
    Neumann HP; Sullivan M; Winter A; Malinoc A; Hoffmann MM; Boedeker CC; Bertz H; Walz MK; Moeller LC; Schmid KW; Eng C
    J Clin Endocrinol Metab; 2011 Aug; 96(8):E1279-82. PubMed ID: 21613359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of pheochromocytomas and paragangliomas.
    Opocher G; Schiavi F
    Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):943-56. PubMed ID: 21115163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular markers of paragangliomas/pheochromocytomas.
    Zhikrivetskaya SO; Snezhkina AV; Zaretsky AR; Alekseev BY; Pokrovsky AV; Golovyuk AL; Melnikova NV; Stepanov OA; Kalinin DV; Moskalev AA; Krasnov GS; Dmitriev AA; Kudryavtseva AV
    Oncotarget; 2017 Apr; 8(15):25756-25782. PubMed ID: 28187001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma.
    Burnichon N; Vescovo L; Amar L; Libé R; de Reynies A; Venisse A; Jouanno E; Laurendeau I; Parfait B; Bertherat J; Plouin PF; Jeunemaitre X; Favier J; Gimenez-Roqueplo AP
    Hum Mol Genet; 2011 Oct; 20(20):3974-85. PubMed ID: 21784903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma.
    Qin Y; Yao L; King EE; Buddavarapu K; Lenci RE; Chocron ES; Lechleiter JD; Sass M; Aronin N; Schiavi F; Boaretto F; Opocher G; Toledo RA; Toledo SP; Stiles C; Aguiar RC; Dahia PL
    Nat Genet; 2010 Mar; 42(3):229-33. PubMed ID: 20154675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rethinking pheochromocytomas and paragangliomas from a genomic perspective.
    Castro-Vega LJ; Lepoutre-Lussey C; Gimenez-Roqueplo AP; Favier J
    Oncogene; 2016 Mar; 35(9):1080-9. PubMed ID: 26028031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identical germline mutations in the TMEM127 gene in two unrelated Japanese patients with bilateral pheochromocytoma.
    Takeichi N; Midorikawa S; Watanabe A; Naing BT; Tamura H; Wakakuri-Kano T; Ishizaki A; Sugihara H; Nissato S; Saito Y; Aita Y; Ishii KA; Igarashi T; Kawakami Y; Hara H; Ikeda T; Shimizu K; Suzuki S; Shimano H; Kawamoto M; Shimada T; Watanabe T; Oikawa S; Takekoshi K
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):707-14. PubMed ID: 22541004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas.
    Korpershoek E; Favier J; Gaal J; Burnichon N; van Gessel B; Oudijk L; Badoual C; Gadessaud N; Venisse A; Bayley JP; van Dooren MF; de Herder WW; Tissier F; Plouin PF; van Nederveen FH; Dinjens WN; Gimenez-Roqueplo AP; de Krijger RR
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1472-6. PubMed ID: 21752896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas.
    Welander J; Söderkvist P; Gimm O
    Endocr Relat Cancer; 2011 Dec; 18(6):R253-76. PubMed ID: 22041710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pheochromocytomas: from genetic diversity to new paradigms.
    Qin Y; Buddavarapu K; Dahia PL
    Horm Metab Res; 2009 Sep; 41(9):664-71. PubMed ID: 19391076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma.
    Galan SR; Kann PH
    Clin Endocrinol (Oxf); 2013 Feb; 78(2):165-75. PubMed ID: 23061808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma.
    Burnichon N; Cascón A; Schiavi F; Morales NP; Comino-Méndez I; Abermil N; Inglada-Pérez L; de Cubas AA; Amar L; Barontini M; de Quirós SB; Bertherat J; Bignon YJ; Blok MJ; Bobisse S; Borrego S; Castellano M; Chanson P; Chiara MD; Corssmit EP; Giacchè M; de Krijger RR; Ercolino T; Girerd X; Gómez-García EB; Gómez-Graña A; Guilhem I; Hes FJ; Honrado E; Korpershoek E; Lenders JW; Letón R; Mensenkamp AR; Merlo A; Mori L; Murat A; Pierre P; Plouin PF; Prodanov T; Quesada-Charneco M; Qin N; Rapizzi E; Raymond V; Reisch N; Roncador G; Ruiz-Ferrer M; Schillo F; Stegmann AP; Suarez C; Taschin E; Timmers HJ; Tops CM; Urioste M; Beuschlein F; Pacak K; Mannelli M; Dahia PL; Opocher G; Eisenhofer G; Gimenez-Roqueplo AP; Robledo M
    Clin Cancer Res; 2012 May; 18(10):2828-37. PubMed ID: 22452945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pheochromocytomas and paragangliomas: implications of new insights for diagnosis and treatment].
    van der Kleij-Corssmit EP; Havekes B; Vriends AH; Jansen JC; Romijn JA
    Ned Tijdschr Geneeskd; 2008 Mar; 152(9):489-93. PubMed ID: 18389879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.